TABLE 3b. Estimated percent for time since first diagnosis among adults1 with active2 asthma by state/territory ā€“ BRFSS Asthma Call-back Survey, United States, 2010

Table 3b
 
State/Territory Sample
sizeĀ±
5 or fewer years More than 5 years
Sample
size
% SEĀ§ 95% CIā€  Sample
size
% SE 95% CI
Alabama 320 44 13.7 2.7 (8.4 ā€“ 19.0) 276 86.3 2.7 (81.0 ā€“ 91.6)
Arizona 286 39 10.3 2.7 (5.0 ā€“ 15.6) 247 89.7 2.7 (84.4 ā€“ 95.0)
California 545 75 15.7 2.3 (11.2 ā€“ 20.2) 470 84.3 2.3 (79.8 ā€“ 88.8)
Connecticut 284 48 17.0 3.8 (9.6 ā€“ 24.4) 236 83.0 3.8 (75.6 ā€“ 90.4)
District of Columbia 153 16 17.2 4.8 (7.8 ā€“ 26.6) 137 82.8 4.8 (73.4 ā€“ 92.2)
Florida 449 67 14.8 3.4 (8.1 ā€“ 21.5) 382 85.2 3.4 (78.5 ā€“ 91.9)
Georgia 176 22 11.7 3.0 (5.8 ā€“ 17.6) 154 88.3 3.0 (82.4 ā€“ 94.2)
Hawaii 288 42 13.1 3.2 (6.8 ā€“ 19.4) 246 86.9 3.2 (80.6 ā€“ 93.2)
Illinois 173 18 N/A N/A (N/A ā€“ N/A) 155 87.5 4.5 (78.7 ā€“ 96.3)
Indiana 509 86 18.2 2.7 (12.9 ā€“ 23.5) 423 81.8 2.7 (76.5 ā€“ 87.1)
Iowa 271 34 13.9 2.7 (8.6 ā€“ 19.2) 237 86.1 2.7 (80.8 ā€“ 91.4)
Kansas 437 56 13.5 2.5 (8.6 ā€“ 18.4) 381 86.5 2.5 (81.6 ā€“ 91.4)
Louisiana 203 26 7.0 1.8 (3.5 ā€“ 10.5) 177 93.0 1.8 (89.5 ā€“ 96.5)
Maine 488 74 16.0 2.9 (10.3 ā€“ 21.7) 414 84.0 2.9 (78.3 ā€“ 89.7)
Maryland 286 40 13.3 2.8 (7.8 ā€“ 18.8) 246 86.7 2.8 (81.2 ā€“ 92.2)
Massachusetts 234 35 16.0 4.1 (8.0 ā€“ 24.0) 199 84.0 4.1 (76.0 ā€“ 92.0)
Michigan 574 88 16.5 2.6 (11.4 ā€“ 21.6) 486 83.5 2.6 (78.4 ā€“ 88.6)
Mississippi 346 48 11.0 2.4 (6.3 ā€“ 15.7) 298 89.0 2.4 (84.3 ā€“ 93.7)
Missouri 282 41 12.9 3.2 (6.6 ā€“ 19.2) 241 87.1 3.2 (80.8 ā€“ 93.4)
Montana 342 51 17.7 4.3 (9.3 ā€“ 26.1) 291 82.3 4.3 (73.9 ā€“ 90.7)
Nebraska 637 94 13.1 2.1 (9.0 ā€“ 17.2) 543 86.9 2.1 (82.8 ā€“ 91.0)
Nevada 168 26 18.8 4.9 (9.2 ā€“ 28.4) 142 81.2 4.9 (71.6 ā€“ 90.8)
New Hampshire 305 45 14.8 3.2 (8.5 ā€“ 21.1) 260 85.2 3.2 (78.9 ā€“ 91.5)
New Jersey 378 56 14.3 2.5 (9.4 ā€“ 19.2) 322 85.7 2.5 (80.8 ā€“ 90.6)
New Mexico 352 45 12.6 2.5 (7.7 ā€“ 17.5) 307 87.4 2.5 (82.5 ā€“ 92.3)
New York 146 15 N/A N/A (N/A ā€“ N/A) 131 90.5 2.9 (84.8 ā€“ 96.2)
North Dakota 188 30 14.2 3.8 (6.8 ā€“ 21.6) 158 85.8 3.8 (78.4 ā€“ 93.2)
Ohio 381 48 10.4 2.1 (6.3 ā€“ 14.5) 333 89.6 2.1 (85.5 ā€“ 93.7)
Oklahoma 366 53 16.1 3.1 (10.0 ā€“ 22.2) 313 83.9 3.1 (77.8 ā€“ 90.0)
Oregon 236 33 22.7 5.8 (11.3 ā€“ 34.1) 203 77.3 5.8 (65.9 ā€“ 88.7)
Pennsylvania 437 75 15.7 2.4 (11.0 ā€“ 20.4) 362 84.3 2.4 (79.6 ā€“ 89.0)
Rhode Island 348 49 12.1 2.3 (7.6 ā€“ 16.6) 299 87.9 2.3 (83.4 ā€“ 92.4)
Texas 721 110 14.0 3.3 (7.5 ā€“ 20.5) 611 86.0 3.3 (79.5 ā€“ 92.5)
Utah 465 59 16.6 3.8 (9.2 ā€“ 24.0) 406 83.4 3.8 (76.0 ā€“ 90.8)
Vermont 439 76 19.8 3.3 (13.3 ā€“ 26.3) 363 80.2 3.3 (73.7 ā€“ 86.7)
Washington 709 87 14.4 2.2 (10.1 ā€“ 18.7) 622 85.6 2.2 (81.3 ā€“ 89.9)
West Virginia 203 32 19.3 4.2 (11.1 ā€“ 27.5) 171 80.7 4.2 (72.5 ā€“ 88.9)
Wisconsin 243 33 N/A N/A (N/A ā€“ N/A) 210 81.4 6.0 (69.6 ā€“ 93.2)
Puerto Rico 157 26 13.2 3.8 (5.8 ā€“ 20.6) 131 86.8 3.8 (79.4 ā€“ 94.2)
39 state total 13,525 1,942 14.2 0.7 (12.8 ā€“ 15.6) 11,583 85.8 0.7 (84.4 ā€“ 87.2)
Median     14.4       85.7    
Range     7.0-22.7       77.3-93.0    

1 Aged ā‰„ 18 years

2 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

Ā± Sample size excludes ā€œDK/Refusedā€

Ā§ Standard error

ā€  Confidence interval

N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30